What is a Leydig cell tumour of the testis?
A Leydig cell tumour is a rare growth of the testicle that starts in the Leydig cells, the cells that make the male hormone testosterone. Because these cells produce hormones, the tumour can release extra testosterone or oestrogen, which may cause noticeable body changes.
Leydig cell tumours are the most common sex cord-stromal tumours of the testis, a group of tumours that arise from the supporting and hormone-making tissue rather than from sperm-forming cells. Overall they account for only about 1-3% of testicular tumours. Most testicular cancers are germ cell tumours (seminomas and non-seminomas), which are different diseases.
The tumour has two age peaks: boys aged about 5 to 10, and men aged about 30 to 60. In boys it may cause early puberty. In men it may cause breast enlargement, low sex drive or infertility, although many tumours are now found by chance on an ultrasound scan.
The great majority of Leydig cell tumours, around 9 in 10, are benign. A small proportion, almost always in older men, behave as cancers and spread (Cheville et al., 1998). Small benign-looking tumours can often be removed while keeping the testicle (Bozzini, Ratti and Carmignani, 2017).
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of tumour | Sex cord-stromal tumour arising from testosterone-producing cells |
| How common | About 1-3% of testicular tumours |
| Age | Boys 5-10 years and men 30-60 years |
| Benign or malignant | About 90% benign; malignant forms mainly in older men |
| Hormone effects | Early puberty in boys; breast swelling, low libido or infertility in men |
| Tumour markers (AFP, hCG) | Usually normal |
| Main treatment | Testis-sparing surgery or removal of the testicle |
| Outlook | Excellent for benign tumours; poorer when the tumour has spread |
2. Benign and malignant Leydig cell tumours
There is no single test that proves a Leydig cell tumour is malignant unless it has already spread. Pathologists look for a group of worrying features.
| Feature | Benign-looking tumour | Features suggesting malignancy |
|---|---|---|
| Size | Usually under 3 cm | Larger, often over 5 cm |
| Cell division | Few mitoses | Many mitoses, including abnormal forms |
| Necrosis | Absent | Present |
| Edges | Well defined | Infiltrating the surrounding testis |
| Spread into vessels | Absent | Present |
| Extension | Confined to the testis | Into the rete testis, epididymis or covering layers |
| Cell atypia | Mild | Marked |
| Proliferation (Ki-67) | Low | High |
In a study of 30 tumours, those that spread were on average larger (4.7 versus 2.6 cm) and showed far more cell division than those that did not (Cheville et al., 1998). Tumours with several of these features are watched more closely.
How it differs from germ cell testicular cancer
| Feature | Leydig cell tumour | Germ cell tumour (seminoma or non-seminoma) |
|---|---|---|
| Cell of origin | Hormone-making Leydig cells | Sperm-forming germ cells |
| Frequency | Rare | About 95% of testicular cancers |
| Hormone effects | Common | Uncommon |
| Blood markers (AFP, hCG) | Normal | Often raised |
| Behaviour | Mostly benign | Malignant |
| Response to chemotherapy | Poor in the rare malignant cases | Usually excellent |
3. Causes and risk factors
The cause is usually unknown. Several conditions are linked with a higher risk.
| Factor | Notes |
|---|---|
| Undescended testicle | History of cryptorchidism |
| Klinefelter syndrome | Leydig cell overgrowth is common in this condition |
| Infertility | Small tumours are often found during fertility tests |
| Hereditary leiomyomatosis and renal cell cancer (HLRCC) | Changes in the fumarate hydratase (FH) gene occur in a minority |
| Hormone imbalance | Long-term high levels of the hormone LH may contribute |
Gene changes
Some Leydig cell tumours show changes in FH, and childhood tumours may carry activating changes in the LH receptor or GNAS genes. Most cases are not inherited. Genetic counselling may be offered if an FH change is found or if there is a family history of kidney cancer and skin or uterine fibroids.
4. How does it look
On the outside
Many tumours are too small to feel and are found only on ultrasound. When felt, the tumour is a firm, painless lump in the testicle. Hormone effects may be the only visible sign.
| Feature | Description |
|---|---|
| Lump | Small, firm, often under 2-3 cm |
| Scrotum | Usually looks normal |
| Breasts | Swollen and sometimes tender (gynaecomastia) in men |
| Boys | Signs of early puberty: pubic hair, deeper voice, penile growth, growth spurt |
On scans
Ultrasound typically shows a small, well-defined, dark (hypoechoic) nodule with blood flow around its edge. Contrast-enhanced ultrasound and MRI can help to distinguish a Leydig cell tumour from a germ cell cancer, because Leydig tumours tend to light up strongly and quickly. A CT scan of the chest, abdomen and pelvis is used if the tumour has malignant features.
Under the microscope
| Feature | Description |
|---|---|
| Cells | Large polygonal cells with plentiful pink cytoplasm |
| Reinke crystals | Rod-shaped crystals seen in a proportion of cases |
| Pigment | Brownish lipochrome pigment in some cells |
| Arrangement | Sheets, nests or cords |
| Stains | Inhibin, calretinin, SF-1 and Melan-A positive |
5. Symptoms
Common symptoms
- A painless lump or swelling in one testicle
- Breast enlargement or tenderness (gynaecomastia) in adult men
- Reduced sex drive or erection problems
- Difficulty fathering children
- No symptoms at all, with the tumour found on a scan
Less common symptoms
| Symptom | What it may mean |
|---|---|
| Early puberty in a boy | Excess testosterone |
| Testicular ache | Larger tumour |
| Back pain | Rarely, spread to lymph nodes at the back of the abdomen |
| Cough or breathlessness | Rarely, spread to the lungs |
| Weight loss | Advanced malignant tumour |
When to seek medical advice
See a doctor about any new lump, swelling or change in a testicle, and about breast swelling in a man or signs of puberty in a young child. Most testicular lumps are not Leydig cell tumours, but all need prompt assessment.
6. Diagnosis
| Test | Purpose |
|---|---|
| Examination | Checks the testicles, breasts and signs of puberty |
| Scrotal ultrasound | Main test for finding and measuring the tumour |
| Tumour markers (AFP, hCG, LDH) | Usually normal; helps rule out germ cell cancer |
| Hormone tests | Testosterone, oestradiol, LH and FSH |
| Semen analysis | Checks fertility, and allows sperm banking before surgery |
| Contrast ultrasound or MRI | Characterises small or uncertain lesions |
| CT scan | Staging if malignancy is suspected |
| Pathology | Confirms the diagnosis after surgery |
Leydig cell tumours in children
In boys, the tumour usually shows itself through signs of early puberty, such as rapid growth, pubic hair, acne, a deeper voice and enlargement of the penis, sometimes before any lump is felt. Doctors check hormone levels and bone age, and rule out other causes of early puberty such as adrenal gland conditions. Childhood tumours are almost always benign, and testis-sparing surgery is usually the preferred operation (Zu’bi et al., 2019). Some boys continue to need monitoring by a paediatric endocrinologist, because puberty can carry on early even after the tumour has been removed.
Staging
| Stage | What it means |
|---|---|
| Stage I | Tumour confined to the testis |
| Stage II | Spread to lymph nodes at the back of the abdomen |
| Stage III | Spread to distant organs such as the lungs, liver or bones |
7. Treatment
Treatment is planned by a urology or testicular cancer team, together with an endocrinologist and, for boys, a paediatric surgeon.
Surgery
| Option | Who it suits | Notes |
|---|---|---|
| Testis-sparing surgery | Small tumours with no worrying features | Removes only the tumour, often guided by ultrasound and checked with frozen section |
| Radical inguinal orchidectomy | Larger tumours, uncertain diagnosis or malignant features | Removes the whole testicle through the groin |
| Retroperitoneal lymph node dissection (RPLND) | Selected malignant tumours | Removes lymph nodes at the back of the abdomen |
A review of 247 patients found that none of the 102 men treated with testis-sparing surgery developed spread of the tumour during follow-up (Bozzini, Ratti and Carmignani, 2017). Testis-sparing surgery is also widely used in children, with good results even when margins were not completely clear (Zu’bi et al., 2019).
Treatment of malignant tumours
Malignant Leydig cell tumours respond poorly to chemotherapy and radiotherapy. Surgery is the main treatment.
| Option | Notes |
|---|---|
| RPLND | May help in early malignant disease; outcomes are poorer once nodes are involved (Hendry et al., 2015) |
| Mitotane | A drug that blocks hormone production; used occasionally |
| Chemotherapy | Limited benefit; used mainly for symptom control |
| Clinical trials | Recommended where available |
Side effects
| Treatment | Possible side effects |
|---|---|
| Testis-sparing surgery | Bruising, swelling, small risk of later removal of the testicle |
| Orchidectomy | Scrotal swelling, change in appearance (a prosthesis can be offered) |
| Loss of hormone production | Low testosterone, especially if the other testicle is weak; testosterone replacement can help |
| RPLND | Abdominal recovery, risk of problems with ejaculation |
What treatment involves day to day
| Stage | What to expect |
|---|---|
| Testis-sparing surgery or orchidectomy | Usually a day case or one night in hospital |
| Recovery | Light activity within a week; avoid heavy lifting for 2-4 weeks |
| Hormone review | Blood tests over the following weeks |
| RPLND, if needed | About a week in hospital and several weeks of recovery |
8. Outlook (prognosis)
| Situation | Usual outcome |
|---|---|
| Benign tumour, completely removed | Cured in nearly all cases |
| Tumour in a child | Excellent; malignant behaviour is almost unheard of |
| Tumour with several worrying features | Higher risk of spread; closer follow-up |
| Tumour that has spread | Poor; often fatal within a few years |
Hormone-related changes such as breast swelling often improve after surgery, though they may not disappear completely. Early puberty changes in boys may only partly reverse.
9. Follow-up
| Follow-up | Purpose |
|---|---|
| Scrotal ultrasound | Checks the remaining testicle and the operated testis |
| Hormone tests | Monitors testosterone and oestrogen |
| CT scans | For tumours with worrying features |
| Growth and puberty monitoring | For boys |
| Duration | Often several years; longer for high-risk tumours |
10. Living with a Leydig cell tumour
- Examine your testicles once a month, after a warm bath or shower, and report any change
- Discuss sperm banking before surgery if fertility is a concern
- Ask about testosterone replacement if you have symptoms of low testosterone
- Ask about a testicular prosthesis if the testicle is removed
- Keep follow-up appointments, even when you feel well, because late spread is possible with high-risk tumours
- Tell your doctor about breast changes that persist or return after surgery
- Seek support from testicular cancer charities, which also help men with rarer tumours
11. Frequently asked questions
| Question | Answer |
|---|---|
| Is a Leydig cell tumour cancer? | Usually not; about 9 in 10 are benign |
| Do I have to lose my testicle? | Not always; small tumours can often be removed alone |
| Will my breasts go back to normal? | Often they improve, but not always completely |
| Will I be able to have children? | Many men can; sperm banking may be offered beforehand |
| Do I need chemotherapy? | Almost never |
| Is it the same as testicular cancer? | It is a different, much rarer tumour from the common germ cell cancers |
| Can boys get it? | Yes, and in children it is almost always benign |
| Can it come back in the other testicle? | Rarely; tumours in both testicles occur in only a small minority |
| Will my testosterone level drop? | Usually not if the other testicle works normally; levels are checked after surgery |
12. Questions to ask your care team
- Does my tumour have any features of malignancy?
- Is testis-sparing surgery possible for me?
- Should I bank sperm before surgery?
- Will I need hormone treatment afterwards?
- What scans will I need, and for how long?
- Should I have genetic testing?
Resources
- Bozzini, G., Ratti, D. and Carmignani, L. (2017) ‘Treatment of Leydig cell tumours of the testis: can testis-sparing surgery replace radical orchidectomy? Results of a systematic review’, Actas Urologicas Espanolas, 41(3), pp. 146-154.
- Cheville, J.C. et al. (1998) ‘Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors’, American Journal of Surgical Pathology, 22(11), pp. 1361-1367.
- Hendry, J. et al. (2015) ‘Retroperitoneal lymph node dissection (RPLND) for malignant phenotype Leydig cell tumours of the testis: a 10-year experience’, SpringerPlus, 4, 20.
- Zu’bi, F. et al. (2019) ‘Testis-sparing surgery for pediatric Leydig cell tumors: evidence of favorable outcomes irrespective of surgical margins’, Urology, 134, pp. 203-208.
- National Cancer Institute (2026) Testicular Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/testicular/hp/testicular-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.